Motivational Interviewing to Promote Sustained Breastfeeding

Overview

1. Evaluate the cultural appropriateness of an intervention protocol related to: a) motivational interviewing technique; b) stool, urine, and breast milk sample collection; and c) infant breastfeeding test weight procedure. 2. Compare Motivational Interviewing with an attention intervention (infant safety) on: a) breastfeeding self-efficacy, b) intended length of breastfeeding, and c) duration of breastfeeding. 3. Examine urine samples of infants for the presence of the inflammatory cytokine (LTE4) and evaluate fecal and breast milk samples of infants for human milk oligosaccharide levels.

Full Title of Study: “Motivational Interviewing to Promote Sustained Breastfeeding (Native American Women)”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Prevention
    • Masking: None (Open Label)

Detailed Description

The incidence of asthma, the most common serious chronic inflammatory disease among children, is rising each year. Therefore nursing interventions aimed at promoting infant immunity and mitigating factors to which the infant may be exposed may reduce the complications of this chronic illness. Breastfeeding is an ideal initial prevention strategy that strengthens the infant's immune system. In addition, the identification of biomarkers that reflect infant immune response sets the stage for the evaluation of nursing interventions targeted to decrease the impact of this chronic inflammatory disease. Although more mothers currently initiate breastfeeding, they do not sustain breastfeeding for the recommended 6 to 12 months. In general, Native American mothers' breastfeed for a shorter period of time and mothers in rural setting have fewer resources to support breastfeeding.

Interventions

  • Behavioral: Motivational Interviewing
    • Client-centered strategy that may decrease ambivalence in behavior performance with attention intervention (infant safety) on: a) breastfeeding self-efficacy, b) intended length of breastfeeding, and c) duration of breastfeeding.

Arms, Groups and Cohorts

  • Experimental: 1 Motivational Interviewing
    • 1 intervention group 1 attention intervention group Behavioral: Motivational Interviewing Client-centered strategy that may decrease ambivalence in behavior performance

Clinical Trial Outcome Measures

Primary Measures

  • Days of any breastfeeding
    • Time Frame: From delivery to 6 months after birth
    • Number of days of any breastfeeding

Secondary Measures

  • Increased Breastfeeding self-efficacy
    • Time Frame: From birth to 6 months after delivery
    • Self-reported maternal satisfaction with breastfeeding
  • Increased intention to breastfeed for 6 months
    • Time Frame: From birth to 6 months
    • Self-reported maternal intention to breastfeed for a 6 month period

Participating in This Clinical Trial

Inclusion Criteria

Inclusion criteria for mothers include ≥ 19 years of age and enrolled in Northern Plains Healthy Start program. Inclusion criteria for infants are birth weight of > 2500 gms, > 37 weeks gestation, a bilirubin of 15 mg%, and no NICU admission to provide a sample of stable infants. Exclusion Criteria:

  • Mothers who report that they will not breastfeed will be excluded. – Infants with a birth weight < 2500 gms, are < 37 weeks gestation, or diagnosed with any significant health problems, significant postnatal problems requiring NICU admission, symptoms of drug withdrawal, or a bilirubin > 15 mg% will be not be recruited for the study.

Gender Eligibility: Female

Minimum Age: 17 Years

Maximum Age: 45 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • University of Nebraska
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Susan M Wilhelm, RNC, PhD, Principal Investigator, University of Nebraska Medical Center, College of Nursing

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.